Anzeige
Mehr »
Sonntag, 06.07.2025 - Börsentäglich über 12.000 News
LiquidLink startet Bitcoin Lightning- und XRP-ILP-Nodes - Aufbau des Rückgrats der tokenisierten Finanzwelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
534 Leser
Artikel bewerten:
(1)

American Screening LLC Has a Wide Range of Testing Kits for Home Use in Stock

SHREVEPORT, LA / ACCESSWIRE / August 27, 2021 / American Screening LLC is a company with the mission to provide high-quality testing products for drugs and alcohol. In time, the corporation grew into a leading contract manufacturer and distributor of diagnostic tests both on the domestic and international markets. ASC has an ISO13485 certification and it also offers other essential medical supplies. Its mission is also expanding to support the fight against addiction to drugs and against mental illness. As part of this commitment, American Screening LLC has made it one of its priorities to maintain a robust selection of home drug testing kits that are both highly accurate and affordably priced.

The most popular at-home drug tests are the ones using urine samples, primarily because they are easy and painless to run and deliver fast results. The kits offered by American Screening LLC can detect from one to as many as 40 drugs of abuse with an accuracy of up to 99%. As defined by the US Food and Drug Administration (FDA), abused drugs are illegal or prescription medicines (for example, Oxycodone or Valium) that are taken for non-medical purposes. The non-medical purposes for a prescription drug include taking the medicine for longer than prescribed or for a different purpose than indicated.

According to the American Screening LLC, at-home tests are popular screening products because they allow people to conduct the procedure in a private setting without compromising the accuracy of the results. Their inventory includes kits that test for a specific substance (typically marijuana) and others that can detect the presence of 2,5,6,10,11, or 12 drugs of abuse, including fentanyl, oxycodone, K2, ETG, cocaine, opiates, methamphetamine, amphetamines, phencyclidine (PCP), benzodiazepine, barbiturates, methadone, ecstasy (MDMA), and oxycodone. In recent years, their tests have been increasingly sought out by parents due to rising illicit drug use among teenagers. This was part of a larger global trend sustained by the accessibility of synthetic drugs and the non-medical use of prescription medicines.

To ensure that its tests are properly run, American Screening LLC provides product inserts and procedure cards for every item listed on its website. In case a buyer still has difficulties running a test, the company's customer service team is readily available to answer any questions, and it has proved of immense help to countless people in need of additional assistance. Apart from being the distribution leader in the rapid diagnostic tests space, with over 250 million strips sold annually, American Screening LLC has remained firmly committed to offering personalized customer support to ensure that its clients receive the best possible product along with expert advice so that they can achieve their health and wellness goals.

Established in 2004 in Shreveport, Louisiana, American Screening LLC quickly garnered a strong reputation as its founder, Ron Kilgarlin, leveraged his expertise in business management, medical devices, product development, distribution, and marketing. Over the years, Ron built the company into a leading provider of diagnostic tests and medical supplies to the United States, South America, Asia, Africa, Europe, and Australia. American Screening LLC is the recipient of multiple certifications, including the highly coveted one issued under MDSAP (Medical Device Single Audit Program), which designates the company as compliant with the requirements for quality management systems in multiple jurisdictions.

American Screening, LLC - Leading Provider of Diagnostic Tests & Medical Supplies: http://americanscreeningcorporationnews.com

American Screening LLC - Ron Kilgarlin - Allows Fast and Effective Decision-Making with Comprehensible Choice of Rapid Tests: https://nyheadline.com/press/american-screening-llc-ron-kilgarlin-allows-fast-and-effective-decisionmaking-with-comprehensible-choice-of-rapid-tests/56453

American Screening, LLC - Ron Kilgarlin - Provides Rapid Antibody Tests: https://scienfinite.com/news/american-screening-llc-ron-kilgarlin-provides-rapid-antibody-tests/326131

Contact Information:
Ron Kilgarlin
American Screening, LLC
9742 St Vincent Ave, Ste 100
Shreveport, LA 71106
1-866-526-2873
sales@americansreeningcorp.com
https://www.americanscreeningcorp.com

SOURCE: American Screening LLC



View source version on accesswire.com:
https://www.accesswire.com/661793/American-Screening-LLC-Has-a-Wide-Range-of-Testing-Kits-for-Home-Use-in-Stock

© 2021 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.